Showing 1 to 1 of 1 results
theglobeandmail.com
🌐 85% Global Worthiness
New Antibiotic Shows Promise Against Drug-Resistant Gonorrhea
A phase 3 clinical trial shows gepotidacin, a new antibiotic, effectively treats gonorrhea in 92.6% of participants, offering a crucial alternative as the infection develops resistance to existing treatments, with infection rates reaching a 30-year high in Canada.
New Antibiotic Shows Promise Against Drug-Resistant Gonorrhea
A phase 3 clinical trial shows gepotidacin, a new antibiotic, effectively treats gonorrhea in 92.6% of participants, offering a crucial alternative as the infection develops resistance to existing treatments, with infection rates reaching a 30-year high in Canada.
Progress
28% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results